High expression of TRIM24 predicts worse prognosis and promotes proliferation and metastasis of epithelial ovarian cancer.

Liwei ZhangHong ChenBaijuan DingWei Jiang

Published in: Journal of ovarian research (2022)

Our results confirmed that TRIM24 could predict poor prognosis of EOC patients and promote tumor progression by regulating Akt pathway and EMT. TRIM24 may be used as a new prognostic marker for EOC and may provide a new strategy for targeted therapy of epithelial ovarian cancer.

Keyphrases

poor prognosis
long non coding rna
end stage renal disease
signaling pathway
newly diagnosed
ejection fraction
chronic kidney disease
cell proliferation
epithelial mesenchymal transition
prognostic factors
binding protein